Please ensure Javascript is enabled for purposes of website accessibility

AMPAC expanding Petersburg operation, adding 156 jobs

Pharmaceutical manufacturer plans to invest $25 million

Kate Andrews //May 4, 2021//

AMPAC expanding Petersburg operation, adding 156 jobs

Pharmaceutical manufacturer plans to invest $25 million

Kate Andrews //May 4, 2021//

Listen to this article

AMPAC Fine Chemicals plans to grow its facility, investing $25 million and creating 156 jobs, announced Tuesday.

AMPAC manufactures active pharmaceutical ingredients (APIs) and is a partner with Richmond-based Corp., ‘s Medicines for All Institute and nonprofit drugmaker , on a federally funded, $354 million contract to reduce America’s dependence on foreign supply chains and produce domestic production sources for medications and pharmaceutical ingredients at risk of shortages, including treatments for .

Phlow was awarded the four-year contract by the U.S. Biomedical Advanced Research and Development Authority (BARDA) in May 2020. This January, Utah-based Civica Inc. announced it would establish its North American manufacturing operation in Petersburg, investing $124.5 million to establish a new facility next to Phlow’s future operation and AMPAC’s existing facility. With Tuesday’s announcement, AMPAC will expand its current plant, where it moved in 2019. Civica’s plant will convert active pharmaceutical ingredients produced by AMPAC and Phlow into vials and syringes to be used in hospitals.

“AMPAC’s investment will further advance the pharmaceutical cluster that has emerged in Petersburg and solidify our commonwealth as a significant player in domestic drug manufacturing,” Northam said in a statement. “This critical partnership between Phlow Corp., Medicines for All Institute, Civica Inc. and AMPAC will have a positive and far-reaching impact, ensuring greater access to high-quality, lifesaving medications while also creating much-needed jobs to support our economic recovery in Virginia.”

AMPAC was founded in 1945 and currently employs 109 people in Virginia, which competed for the project against California and Texas, where AMPAC has two other operations.

“Of our three AMPAC locations, Virginia offers an enabling environment for developing and sustaining the growth in capacity and infrastructure demanded for the pharmaceutical industry,” William DuBay, AMPAC global vice president of research and development, said in a statement. “Our growing relationship with the commonwealth, [the Virginia Partnership], the city of Petersburg and others, including VCU, Phlow and Civica, is a cornerstone of our vision for American-based manufacturing of critical pharmaceutical ingredients.”

VEDP worked with the city of Petersburg, Virginia’s Gateway Region, the Community College Workforce Alliance and Dominion Energy Inc. to secure the project, and Northam approved a $640,000 opportunity fund grant and a $250,000 Virginia Investment Performance grant. VEDP’s Virginia Talent Accelerator Program will provide training and recruitment to AMPAC at no cost to the company.

p
YOUR NEWS.
YOUR INBOX.
DAILY.

By subscribing you agree to our Privacy Policy.